Advertisement Braemar launches new wireless cardiac arrhythmia monitor - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Braemar launches new wireless cardiac arrhythmia monitor

Braemar, a subsidiary of Biotel, has introduced the ER920W, an advanced wireless device that integrates cardiac arrhythmia monitoring and cell phone technologies in one unit.

Braemar’s ER920W is a digital loop recorder with on-board arrhythmia detection algorithms for automatic detection, recording and immediate transmission of patient data files to a service center for analysis and physician attention.

Transmission occurs without patient interaction and without connection through a separate cell phone, reducing potential anomalies in the prescribed testing routine and avoiding the possibility of the patient forgetting to carry the cell phone.

Harry Strandquist, president of Braemar, said: “The ER920W is an advanced arrhythmia monitor with proprietary technology that we believe represents the next generation of cardiac event monitoring.”